Medical Technology

CDC Drops Omicron Estimate of Coronavirus Variants in the US to 58.6 percent

According to the data provided by the U.S. Centers for Disease Control and Prevention on Tuesday the Omicron variant was 58.6% of all coronavirus variants that were circulating within the United States as Dec. 25, according the CDC.

The agency also reduced the Omicron percentage of cases for the week that ended December 18 from 73% to 22 percent, citing additional data as well as the rapid spread of the variant which partially caused the discrepancy.

“We have more data coming from that time period and there was a reduced proportion of Omicron,” a CDC spokesperson stated. “It is important to keep in mind that we’re still seeing an increase in Omicron.”

The fast-spreading variant was first detected in southern Africa and Hong Kong in November, with the first case in the United States identified on Dec. 1 in a vaccine-vaccinated person who had traveled to South Africa.

The strain has quickly spread around the world, causing an increase in U.S. infections. This has led to a plethora of flight cancellations and ruined expectations for the normal holiday season.

The Delta variant is the predominant strain for the past few months , accounts for 41.1 percent U.S. COVID-19 patients as of Dec. 25 according to data from the public health agency.

Scott Gottlieb , former U.S. Food and Drug Administration Commissioner, said on Twitter: “If the CDC’s new estimate for Omicron prevalence is accurate it implies that an important portion of the current hospitalizations may still have been caused by Delta infections.”

The agency said the data include modeled projections that could differ from weighted estimates generated at later dates.

Content Source:

The Medical Progress

The Medical Progress is here to provide news for the medical industry on a daily basis which are mainly on the medical cannabis and it’s legalisation.

Related Articles